JUVENILE MYELOMONOCYTIC LEUKEMIA
Clinical trials for JUVENILE MYELOMONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new JUVENILE MYELOMONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for JUVENILE MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New stem cell method may cut transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests a new way to prepare donor stem cells for transplant in people with blood cancers like leukemia. By removing certain immune cells from the donated cells, researchers hope to lower the risk of graft-versus-host disease, a serious side effect. The study involves 70…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated May 26, 2026 06:36 UTC
-
Immune cell boost shows promise for leukemia relapse after transplant
Disease control Recruiting nowThis early-phase trial tests a special type of immune cell (CIML NK cells) combined with a low dose of IL-2 in people whose blood cancer (AML, MDS, MPN, or JMML) has returned after a stem cell transplant. The main goal is to find the safest dose and see if it can put the cancer b…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 06:25 UTC
-
New cell addback aims to slash infection risk in child cancer transplant patients
Disease control Recruiting nowThis study is for children under 25 who have had a stem cell transplant for blood cancers like leukemia. After transplant, their immune system is weak, putting them at high risk for dangerous infections. Researchers are adding back a specific type of donor cell (CD45RA-depleted) …
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Engineered immune cells take aim at returning leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment for children and adults with acute leukemia that has come back or not responded after a donor stem cell transplant. The treatment uses specially engineered immune cells (T cells) from the original donor that are trained to recognize an…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New study seeks to sharpen diagnosis of rare childhood blood cancers
Knowledge-focused Recruiting nowThis study aims to improve how doctors diagnose two rare blood cancers in children: myelodysplastic syndromes (MDS) and juvenile myelomonocytic leukemia (JMML). Researchers will use standardized lab tests and genetic analysis to better understand these diseases. The study will en…
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Sponsor: University Hospital Freiburg • Aim: Knowledge-focused
Last updated May 26, 2026 06:38 UTC
-
New hope for kids with tough leukemias: screening trial matches patients to targeted therapies
Knowledge-focused Recruiting nowThis study screens children and young adults (under 22) with leukemia that has returned or is difficult to treat. By analyzing their blood and bone marrow, doctors can identify specific genetic markers to match them with the most promising experimental treatments. The goal is to …
Matched conditions: JUVENILE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: PedAL BCU, LLC • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC